FINWIRES · TerminalLIVE
FINWIRES

Jarden Adjusts Bank of Queensland's Price Target to AU$5.50 from AU$6, Keeps at Sell

-- Bank of Queensland (ASX:BOQ) has an average rating of underweight and mean price target of AU$6.27, according to analysts polled by FactSet.

(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

Related Articles

Australia

Oracle Needs More Clarity in GPUaaS Margin Profile, Morgan Stanley Says

Oracle (ORCL) showed improved confidence in Q3 with execution and demand, but uncertainty persists around GPU as a Service business margin, Morgan Stanley said in a Thursday note.The report said Oracle shares have risen more than 20% over the past two weeks partly on continued strength in AI compute demand data points and improved sentiment on compute capex."Further improvement in investor sentiment on AI related hyperscaler/neocloud capex and customer concentration risk could yield further upside," the report said."However additional clarity in the gross margin profile of the GPUaaS business and financing path going forward (and a right-sizing of longer-term targets) would be needed to get more strategically positive on the shares," the note added.Morgan Stanley kept its equal weight rating while lowering its price target to $207 from $213 on balanced risk-reward profile.Price: $177.79, Change: $-9.71, Percent Change: -5.18%

$ORCL
Australia

Morgan Stanley Adjusts Hasbro Price Target to $122 From $119, Maintains Overweight Rating

Hasbro (HAS) has an average rating of overweight and mean price target of $115.69, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $98.71, Change: $+8.10, Percent Change: +8.93%

$HAS
Australia

Barclays Adjusts Price Target on Elevance Health to $408 From $393, Maintains Overweight Rating

Elevance Health (ELV) has an average rating of overweight and mean price target of $376.24, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $342.37, Change: $+14.17, Percent Change: +4.32%

$ELV